INTEST CORP
For the period ended Dec 31, 2023. Filed Mar 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. OTHER INFORMATION
On* December 8, 2023,Richard N. Grant, the Company’s Chief Executive Officer, entered into a prearranged stock trading plan (the “Grant10b5*-1 Plan”). The Grant10b5-1 Plan was entered into during an open insider trading window, is designed to satisfy the affirmative defense of Rule10b5-1(c), and terminates on* December 31, 2026.The Grant10b5*-1 Plan provides for the sale from time to time upon a vesting event of a number of shares equal to40% of the fair market value of the shares that vest upon such vesting event for the purpose of covering applicable taxes due at such vesting event. The plan also has aone-time sale of Common Stock with an aggregate valuenot to exceed$775,000.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.